Anti-Adhesion Product

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 32/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Intraperitoneal Adhesions

Conditions

Intraperitoneal Adhesions

Trial Timeline

Dec 1, 2000 → Apr 1, 2003

NCT ID

NCT00512356

About Anti-Adhesion Product

Anti-Adhesion Product is a phase 2 stage product being developed by Baxter for Intraperitoneal Adhesions. The current trial status is completed. This product is registered under clinical trial identifier NCT00512356. Target conditions include Intraperitoneal Adhesions.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00512356	Phase 2	Completed	Dec 1, 2000	Apr 1, 2003	Intraperitoneal Adhesions